Table of contents
Volume 85, Issue 4
Published online 14 August 2001 (473-636)
Reviews
Chronic immune activation and inflammation as the cause of malignancy FREE
K J O'Byrne and A G Dalgleish
Br J Cancer 85: 473-483; doi:10.1054/bjoc.2001.1943
The pharmacologic basis of high dose chemotherapy with haematopoietic stem cell support for solid tumours FREE
L F Porrata and A A Adjei
Br J Cancer 85: 484-489; doi:10.1054/bjoc.2001.1970
Hypothesis
Does surgery modify growth kinetics of breast cancer micrometastases? FREE
R Demicheli, P Valagussa and G Bonadonna
Br J Cancer 85: 490-492; doi:10.1054/bjoc.2001.1969
Regular Articles
Neuroblastoma in monozygotic twins – a case of probable twin-to-twin metastasis FREE
J Anderson, H Kempski, L Hill, D Rampling, T Gordon and A Michalski
Br J Cancer 85: 493-495; doi:10.1054/bjoc.2001.1979
Pain and health-related quality of life in a geographically defined population of men with prostate cancer FREE
G Sandblom, P Carlsson, P Sigsjö and E Varenhorst
Br J Cancer 85: 497-503; doi:10.1054/bjoc.2001.1965
Liver metastases from colorectal cancer: regional intra-arterial treatment following failure of systemic chemotherapy FREE
A Cyjon, M Neuman-Levin, E Rakowsky, F Greif, A Belinky, E Atar, R Hardoff, B Brenner and A Sulkes
Br J Cancer 85: 504-508; doi:10.1054/bjoc.2001.1972
Factors predicting efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU) 
folinic acid in a compassionate-use cohort of 481 5-FU-resistant advanced colorectal cancer patients FREE
M A Bensmaïne, M Marty, A de Gramont, S Brienza, F Lévi, M Ducreux, E François, E Gamelin, H Bleiberg and E Cvitkovic
Br J Cancer 85: 509-517; doi:10.1054/bjoc.2001.1953
IL-6 gene amplification and expression in human glioblastomas FREE
A Tchirkov, C Rolhion, S Bertrand, J-F Doré, J-J Dubost and P Verrelle
Br J Cancer 85: 518-522; doi:10.1054/bjoc.2001.1942
Genetic analysis of the APC gene regions involved in attenuated APC phenotype in Israeli patients with early onset and familial colorectal cancer FREE
A Figer, L Irmin, R Geva, D Flex, A Sulkes and E Friedman
Br J Cancer 85: 523-526; doi:10.1054/bjoc.2001.1959
A common founder for the V126D CDKN2A mutation in seven North American melanoma-prone families FREE
A M Goldstein, L Liu, M G Shennan, D Hogg, M A Tucker and J P Struewing
Br J Cancer 85: 527-530; doi:10.1054/bjoc.2001.1944
Neuroblastomas with chromosome 11q loss and single copy MYCN comprise a biologically distinct group of tumours with adverse prognosis FREE
M E M Oude Luttikhuis, J E Powell, S A Rees, T Genus, S Chughtai, P Ramani, J R Mann and C M McConville
Br J Cancer 85: 531-537; doi:10.1054/bjoc.2001.1960
Molecular profiles of BRCA1-mutated and matched sporadic breast tumours: relation with clinico-pathological features FREE
E M J J Berns, I L van Staveren, L Verhoog, A M W van de Ouweland, M Meijer-van Gelder, H Meijers-Heijboer, H Portengen, J A Foekens, L C J Dorssers and J G M Klijn
Br J Cancer 85: 538-545; doi:10.1054/bjoc.2001.1937
Expression of Rb2/p130 in breast and endometrial cancer: correlations with hormone receptor status FREE
K Milde-Langosch, C Goemann, C Methner, G Rieck, A-M Bamberger and T Löning
Br J Cancer 85: 546-551; doi:10.1054/bjoc.2001.1923
Prognostic utility of human complement factor H related protein test (the BTA stat ®Test) FREE
M-P Raitanen, E Kaasinen, E Rintala, E Hansson, P Nieminen, R Aine, T L J Tammela and The Finn Bladder Group
Br J Cancer 85: 552-556; doi:10.1054/bjoc.2001.1938
Frequency of PSA-mRNA-bearing cells in the peripheral blood of patients after prostate biopsy FREE
N Hara, T Kasahara, T Kawasaki, V Bilim, Y Tomita, K Obara and K Takahashi
Br J Cancer 85: 557-562; doi:10.1054/bjoc.2001.1924
Hypomethylation of the MN/CA9 promoter and upregulated MN/CA9 expression in human renal cell carcinoma FREE
M Cho, H Uemura, S-C Kim, Y Kawada, K Yoshida, Y Hirao, N Konishi, S Saga and K Yoshikawa
Br J Cancer 85: 563-567; doi:10.1054/bjoc.2001.1951
Functional analysis of the mismatch repair system in bladder cancer FREE
T Thykjaer, M Christensen, A B Clark, L R T Hansen, T A Kunkel and T F Ørntoft
Br J Cancer 85: 568-575; doi:10.1054/bjoc.2001.1949
Correlation of vascular endothelial growth factor expression with fibroblast growth factor-8 expression and clinico-pathologic parameters in human prostate cancer FREE
A F West, M O'Donnell, R G Charlton, D E Neal and H Y Leung
Br J Cancer 85: 576-583; doi:10.1054/bjoc.2001.1971
Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors FREE
R M Shaheen, S A Ahmad, W Liu, N Reinmuth, Y D Jung, W W Tseng, K E Drazan, C D Bucana, D J Hicklin and L M Ellis
Br J Cancer 85: 584-589; doi:10.1054/bjoc.2001.1936
Prostate epithelial cell lines form spheroids with evidence of glandular differentiation in three-dimensional Matrigel cultures FREE
S H Lang, R M Sharrard, M Stark, J M Villette and N J Maitland
Br J Cancer 85: 590-599; doi:10.1054/bjoc.2001.1967
Hyaluronan production increases the malignant properties of mesothelioma cells FREE
Y Li and P Heldin
Br J Cancer 85: 600-607; doi:10.1054/bjoc.2001.1922
An orthotopic xenograft model of human nonseminomatous germ cell tumour FREE
M L Douglas, K J Boucaut, T M Antalis, C Higgins, M F Pera, M A Stuttgen and D L Nicol
Br J Cancer 85: 608-611; doi:10.1054/bjoc.2001.1884
Enhanced VEGF production and decreased immunogenicity induced by TGF-
1 promote liver metastasis of pancreatic cancer FREE
H Teraoka, T Sawada, T Nishihara, M Yashiro, M Ohira, T Ishikawa, H Nishino and K Hirakawa
Br J Cancer 85: 612-617; doi:10.1054/bjoc.2001.1941
Differences between human breast cell lines in susceptibility towards growth inhibition by genistein FREE
K Dampier, E A Hudson, L M Howells, M M Manson, R A Walker and A Gescher
Br J Cancer 85: 618-624; doi:10.1054/bjoc.2001.1980
The chemopotentiation of cisplatin by the novel bioreductive drug AQ4N FREE
R Gallagher, C M Hughes, M M Murray, O P Friery, L H Patterson, D G Hirst and S R McKeown
Br J Cancer 85: 625-629; doi:10.1054/bjoc.2001.1975
Metabolism and growth inhibition of four retinoids in head and neck squamous normal and malignant cells FREE
I Klaassen, R H Brakenhoff, S J Smeets, G B Snow and B J M Braakhuis
Br J Cancer 85: 630-635; doi:10.1054/bjoc.2001.1952
Calendar
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
